RCYC
IHE icon

Richard C. Young & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Richard C. Young & Co’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-81,891
Closed -$3.82M – 70
2019
Q3 		$3.82M Buy
+81,891
New +$3.92M 0.69% 51

Other funds holding IHE

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Richard C. Young & Co's IHE Position: Q4 2019 in Review

Richard C. Young & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2019, closing a stake of 81,891 shares — an estimated $3.82M sold.

Richard C. Young & Co first reported a position in IHE in Q3 2019 and held it in 1 quarter. The position peaked at $3.82M in Q3 2019. 95 funds tracked by Wall St. Rank hold IHE as of Q4 2019.

  • Richard C. Young & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
  • Richard C. Young & Co sold 81,891 iShares US Pharmaceuticals ETF shares in Q4 2019, an estimated $3.82M.
  • Richard C. Young & Co first reported a position in iShares US Pharmaceuticals ETF in Q3 2019 and held it in 1 quarter.
  • Richard C. Young & Co's iShares US Pharmaceuticals ETF position peaked at $3.82M in Q3 2019.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2019.

Based on Richard C. Young & Co's 13F filing for Q4 2019, filed 12 Feb 2020.